Promising new strategy to halt pancreatic cancer metastasis

March 2, 2015, Rockefeller University Press
High expression levels of IL-17B and its receptor (brown) in pancreatic cancer (left) compared with normal tissue (right). Credit: Wu et al., 2015

Pancreatic cancer and its metastases might have their days numbered, according to a study published in The Journal of Experimental Medicine.

Despite substantial progress in treating , this disease is still considered largely incurable. The is mostly due to metastases to other vital organs, a process driven by soluble factors present in the tumor environment.

A secreted immune protein called interleukin(IL)-17 has been associated with cancer progression, and receptors for IL-17 are expressed in the pancreas. Wen-Hwa Lee and colleagues from the Academia Sinica in Taiwan now show that one type of IL-17 (IL-17B) and its receptor are highly expressed in pancreatic cancer, and their levels correlate with poor patient survival. In mice, secretion of IL-17B promoted the growth and metastasis of pancreatic cancer cells and enhanced the recruitment of inflammatory cells to the tumor site. Treating tumor-bearing mice with a drug that prevented IL-17B from binding to its receptor halted tumor growth and spread, resulting in increased survival.

Since are the leading cause of death in pancreatic cancer patients, this drug might represent a novel therapeutic approach to defeat pancreatic cancer and prolong patient survival.

Tumor growth and metastasis have been blocked in mice 28 days after treatment with a drug that prevents IL-17B from binding to its receptor (right) compared with untreated mice (left). Credit: Wu et al., 2015

Explore further: Researchers learning more about deadly pancreatic cancer

More information: Wu, H.-H., et al. 2015. J. Exp. Med. DOI: 10.1084/jem.20141702

Related Stories

Researchers learning more about deadly pancreatic cancer

January 30, 2015
(HealthDay)—Scientists are working to find new ways to treat pancreatic cancer, one of the deadliest types of cancer in the United States.

Armed virus shows promise as treatment for pancreatic cancer

December 23, 2014
A PCRF-funded project which combines of two different approaches – virotherapy and immunotherapy - is showing "great promise" as a treatment for pancreatic cancer.

Researchers identify pancreatic cancer patients who benefit from personalized treatment

February 26, 2015
Cancer researchers at Indiana University report that about 15 percent of people with pancreatic cancer may benefit from therapy targeting a newly identified gene signature.

What makes pancreatic cancer so aggressive? New study sheds light

January 15, 2015
New research from the University of Michigan Comprehensive Cancer Center helps explain why pancreatic cancer is so lethal, with fewer than a third of patients surviving even early stage disease.

Eliminating cellular stroma could enable anti-cancer drugs to penetrate tumor tissues, improve survival

February 24, 2015
Like a stealth jet cloaks itself from radar, cancer cells cloak themselves within tumors by hiding behind a dense layer of cellular material known as stroma.

How tumor-causing cells are recruited in cancers linked to chronic inflammation

February 9, 2015
Chronic inflammation is directly associated with several types of cancer, yet the reasons as to why this happens at a cellular level remain unclear. Now, an international team of scientists led by researchers at The Wistar ...

Recommended for you

Function of neutrophils during tumor progression unraveled

October 15, 2018
Researchers at The Wistar Institute have characterized the function of neutrophils, a type of white blood cells, during early stages of tumor progression, showing that they migrate from the bone marrow to distant sites and ...

Delving where few others have gone, leukemia researchers open new path

October 15, 2018
A Wilmot Cancer Institute study uncovers how a single gene could be at fault in acute myeloid leukemia (AML), one of the deadliest cancers. The breakthrough gives researchers renewed hope that a gene-targeted therapy could ...

3-D mammography detected 34% more breast cancers in screening

October 15, 2018
In traditional mammography screening, all breast tissue is captured in a single image. Breast tomosynthesis, on the other hand, is three-dimensional and works according to the same principle as what is known as tomography. ...

More clues revealed in link between normal breast changes and invasive breast cancer

October 15, 2018
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process—changes in mammary glands to accommodate breastfeeding—uses a molecular process believed ...

Cancer stem cells use 'normal' genes in abnormal ways

October 12, 2018
CDK1 is a "normal" protein—its presence drives cells through the cycle of replication. And MHC Class I molecules are "normal" as well—they present bits of proteins on the surfaces of cells for examination by the immune ...

Obesity linked to increased risk of early-onset colorectal cancer

October 12, 2018
Women who are overweight or obese have up to twice the risk of developing colorectal cancer before age 50 as women who have what is considered a normal body mass index (BMI), according to new research led by Washington University ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.